Filing Flows

Filing Flows › Cryoport (CYRX) › Guidance & outlook

Cryoport (CYRX) guidance and outlook

Cryoport (CYRX) raised its guidance on Nov 5, 2026: Revenue $197M–$199M for FY2026. Cryoport's 10-Q filed Nov 5, 2026 makes 6 forward-looking statements.

Guidance and outlook

Cryoport: what its forward-looking statements are about (10-Q filed 2026-11-05)Cryoport: what its forward-looking statements are about (10-Q filed 2026-11-05)Financing2Other2Deals1Costs1
6 statements; tone +0.33 (−1 all cautious, +1 all confident); 1 hedged.
Cryoport: outlook statements against the filing beforeCryoport: outlook statements against the filing beforeConfident2

Latest guidance

MetricPeriodRangeChange
RevenueFY2026$197M–$199Mraised

From the earnings release filed Nov 5, 2026 (8-K on EDGAR).

Forward-looking statements, 10-Q filed Nov 5, 2026

Cryoport's latest quarter

Cryoport, Q3 2026: revenue $50.2M (+14% year over year), operating margin -17.5%, net loss $10.9M, operating cash flow $5.2M. The chart follows the revenue to costs, profit and cash.

Questions

Did Cryoport raise or lower its guidance?

Cryoport (CYRX) raised its guidance on Nov 5, 2026: Revenue $197M–$199M for FY2026.

What does Cryoport expect?

The divestiture and strategic partnership with DHL are expected to enhance the Company’s ability to develop its business, particularly in the EMEA and APAC regions, and to provide differentiated and high-value services aligned with the Company’s long-term growth strategy. The Company intends to use a portion of its existing cash, cash equivalents, and short-term investments to repay the $186.2 million principal amount of its outstanding 0.75% Convertible Senior Notes due in 2026 (the “2026 Convertible Senior Notes”) upon maturity in December 2026. Following this repayment, the Company expects

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.